Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.3.3 was added to the page history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision history now shows an added entry for v3.3.2 and a removed entry for v3.2.0. This is an administrative update to the history log; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange Detected- Removed the funding-lapse notice that warned about potential delays and directed users to opm.gov.SummaryDifference0.6%

- Check65 days agoChange DetectedThe latest version updates the record with changes to the study status and recruitment status, reflecting the trial's current state and related details.SummaryDifference0.1%

- Check93 days agoChange Detected- Added a government funding and operating status notice and operating details for NIH Clinical Center. - Updated software version from v3.1.0 to v3.2.0.SummaryDifference11%

- Check101 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.